HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 168 filers reported holding HEALTH CATALYST INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,988 | -15.1% | 1,250 | 0.0% | 0.01% | -16.7% |
Q1 2024 | $9,413 | -18.7% | 1,250 | 0.0% | 0.01% | -33.3% |
Q4 2023 | $11,575 | -8.5% | 1,250 | 0.0% | 0.01% | -10.0% |
Q3 2023 | $12,650 | -19.0% | 1,250 | 0.0% | 0.01% | -16.7% |
Q2 2023 | $15,625 | +7.1% | 1,250 | 0.0% | 0.01% | +9.1% |
Q1 2023 | $14,588 | +9.8% | 1,250 | 0.0% | 0.01% | +10.0% |
Q4 2022 | $13,288 | +10.7% | 1,250 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $12,000 | +200.0% | 1,250 | +400.0% | 0.01% | +233.3% |
Q2 2022 | $4,000 | -42.9% | 250 | 0.0% | 0.00% | -40.0% |
Q1 2022 | $7,000 | -30.0% | 250 | 0.0% | 0.01% | -16.7% |
Q4 2021 | $10,000 | -68.8% | 250 | -61.2% | 0.01% | -75.0% |
Q3 2021 | $32,000 | -3.0% | 645 | +9.1% | 0.02% | 0.0% |
Q2 2021 | $33,000 | -2.9% | 591 | -19.4% | 0.02% | -11.1% |
Q1 2021 | $34,000 | -15.0% | 733 | -20.0% | 0.03% | -20.6% |
Q4 2020 | $40,000 | -43.7% | 916 | -52.5% | 0.03% | -46.9% |
Q3 2020 | $71,000 | +373.3% | 1,928 | +274.4% | 0.06% | +300.0% |
Q2 2020 | $15,000 | – | 515 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
Olympiad Research LP | 18,987 | $121,327 | 0.09% |